Literature DB >> 8049464

Antioxidant benefits of tamoxifen therapy for breast cancer?

H Wiseman, C Rice-Evans, B Halliwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8049464     DOI： 10.1007/bf00666485

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  10 in total

1.  The case for clinical trials of tamoxifen for prevention of breast cancer.

Authors:  T J Powles
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

3.  The antioxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidation.

Authors:  H Wiseman; M J Laughton; H R Arnstein; M Cannon; B Halliwell
Journal:  FEBS Lett       Date:  1990-04-24       Impact factor: 4.124

4.  Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.

Authors:  R R Love; D A Wiebe; P A Newcomb; L Cameron; H Leventhal; V C Jordan; J Feyzi; D L DeMets
Journal:  Ann Intern Med       Date:  1991-12-01       Impact factor: 25.391

5.  Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?

Authors:  H Wiseman; G Paganga; C Rice-Evans; B Halliwell
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

6.  Overview from the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer.

Authors:  V C Jordan
Journal:  J Natl Cancer Inst       Date:  1992-02-19       Impact factor: 13.506

7.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors:  M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

8.  17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages.

Authors:  L A Huber; E Scheffler; T Poll; R Ziegler; H A Dresel
Journal:  Free Radic Res Commun       Date:  1990

9.  Tamoxifen suppresses tumor promoter-induced hydrogen peroxide formation by human neutrophils.

Authors:  J S Lim; K Frenkel; W Troll
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

10.  Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters.

Authors:  H Wei; K Frenkel
Journal:  Carcinogenesis       Date:  1993-06       Impact factor: 4.944
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.